Imprint cytology. A rapid, reliable method of diagnosing breast malignancy

S Veneti1, L Ioannidou-Mouzaka, H Toufexi

  • 1Cytology Department, LETO Maternity Hospital, Athens, Greece.

Acta Cytologica
|July 1, 1996
PubMed

Insights

Imprint cytology offers high accuracy for intraoperative breast cancer diagnosis, serving as a viable alternative to frozen sections when pathology labs are unavailable. This method demonstrates superior performance compared to aspiration cytology.

Area of Science:

  • Oncology
  • Pathology
  • Surgical Diagnostics

Background:

  • Intraoperative diagnosis of breast malignancy is crucial for guiding surgical decisions.
  • Frozen section analysis is the standard but requires specialized laboratory facilities.
  • Alternative rapid diagnostic methods are needed, especially in resource-limited settings.

Purpose of the Study:

  • To compare the diagnostic accuracy of imprint cytology with fine needle aspiration biopsy and histopathology for intraoperative assessment of breast lesions.
  • To evaluate imprint cytology as a potential alternative to frozen section analysis.

Main Methods:

  • A study involving 351 breast cases (180 benign, 171 malignant) was conducted.
  • Diagnostic techniques included fine needle aspiration cytology, imprint cytology, and histopathology.
  • Comparative analysis of accuracy, sensitivity, and specificity was performed against histopathology as the gold standard.

Main Results:

  • Imprint cytology demonstrated high diagnostic accuracy (98.3%), sensitivity (97.1%), and specificity (99.4%) when compared to histopathology.
  • Fine needle aspiration cytology showed lower accuracy (94.9%), sensitivity (93.9%), and specificity (96.2%) compared to histopathology.
  • Imprint cytology outperformed aspiration cytology in accuracy, sensitivity, and specificity.

Conclusions:

  • Imprint cytology is a valuable tool for the intraoperative diagnosis of breast malignancy.
  • It can be utilized as an effective alternative to frozen section analysis, particularly when a pathology laboratory is inaccessible.
  • The findings support the integration of imprint cytology into routine intraoperative breast cancer diagnostics.
Abstract